Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04308590
Title Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas (GRADIENT)
Acronym GRADIENT
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Corcept Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ROU | POL | ITA | ISR | ESP | DEU | BGR | AUT

Facility Status City State Zip Country Details
Site 27 Birmingham Alabama 35294 United States Details
Site 17 Stanford California 94305 United States Details
Site 53 Torrance California 90502 United States Details
Site 07 Atlanta Georgia 30318 United States Details
Site 16 Indianapolis Indiana 46202 United States Details
Site 09 Metairie Louisiana 70006 United States Details
Site 36 Baltimore Maryland 21287 United States Details
Site 11 Fall River Massachusetts 02721 United States Details
Site 33 Rochester Minnesota 55905 United States Details
Site 06 Jackson Mississippi 39202 United States Details
Site 54 Reno Nevada 89511 United States Details
Site 10 Jamaica New York 11432 United States Details
Site 44 New York New York 10021 United States Details
Site 01 Wilmington North Carolina 28401 United States Details
Site 30 Cleveland Ohio 44195 United States Details
Site 21 Columbus Ohio 43201-3209 United States Details
Site 02 Summerville South Carolina 29485 United States Details
Site 20 Dallas Texas 75390 United States Details
Site 03 El Paso Texas 79935 United States Details
Site 05 Fort Worth Texas 76132 United States Details
Site 08 Houston Texas 77079 United States Details
Site 15 Spokane Washington 99202 United States Details
Site 25 Wien Vienna 1090 Austria Details
Site 22 Sofia 01431 Bulgaria Details
Site 50 Munich Bavaria 80336 Germany Details
Site 46 Wuerzburg 97080 Germany Details
Site 32 Ramat Gan 5265601 Israel Details
Site 23 Tel Aviv Israel Details
Site 40 Milan Milano 20122 Italy Details
Site 31 Rome Roma 00189 Italy Details
Site 43 Orbassano Torino Italy Details
Site 34 Milan Italy Details
Site 28 Napoli 80131 Italy Details
Site 51 Padova 35128 Italy Details
Site 37 Rome 00161 Italy Details
Site 52 Torino 10126 Italy Details
Site 48 Gliwice 44-102 Poland Details
Site 47 Krakow 31-501 Poland Details
Site 35 Lublin Poland Details
Site 42 Bucharest 010825 Romania Details
Site 38 Bucharest 011863 Romania Details
Site 41 Bucharest 011863 Romania Details
Site 14 Malaga 29006 Spain Details
Site 13 Sevilla 41013 Spain Details
Site 26 Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field